GrahamB wrote: DavidRosenberg wrote:
TryN2Learn wrote: Would any of you be able to answer the question:
"there was the issuance of 4,502,392 Class B Subordinate voting shares in the capital of FSD Pharma".... Does this mean that FSD Pharma created these shares in order to purchase Lucid? Any feedback from anybody would be greatly appreciated, thank you in advance.
yes these shares were created and given as part of the deal to accuire lucid
4.5m shares is nothing compared to what previous management did from 7.89m shares to 36m shares
David
Seriously
Do you remember all the shares Anthony and crew received in the past -and he was part of the management!
Here are a few little facts from the past :
FSD Pharma Issues $5.2 Million Worth Of Shares To Management As Compensation
On Monday, the company filed a notice of issuance of listed securities form with the Canadian Securities Exchange, indicating $5.2 million worth of shares had been issued by the company. The kicker, is that the issuance was directly to the firms executive team.
The notice of the share issuance was discreetly listed at the bottom of a July 31, 2020 news released filed by the company, in connection with a US $10 million registered direct offering. At the time, 1,322,927 Class B common shares of the issuer were to be issued to its directors and management team as compensation. That figure however climbed to 1,692,182 Class B common shares by the date of issuance – growing the firms share count by 15.7% in the process.
The largest distribution went to the firms CEO, Raza Bokhari, whom received 805,802 shares in total, or roughly half of the issuance, at a deemed price of $3.1025, the equivalent of $2.5 million. Issuance’s to other members of management was rather sporadic, with some directors and executives not receiving any shares at all.
Each of Edward Brennan, Steve Buyer, Donal Carroll, Robert Claruffoli and David Urban received 80,580 shares in the issuance, while Zeeshan Saeed and Anthony Durkacz received 161,160 shares. Director Gerry Goldberg received the smallest issuance, at 32,232 shares.
https://thedeepdive.ca/fsd-pharma-issues-5-2-million-worth-of-shares-to-management-as-compensation/
It seems you either have no insight ,obscure, or don’t care that you lack a basic understandiing of financial statements, the mechanics of investing, and the truth of FSD.
We also remember when you told the board you were also offered shares for your work in the board